Novartis, already trialing hydroxychloroquine and Jakafi, plans COVID-19 testing for Ilaris

28th April 2020 Uncategorised 0

Another existing drug is being pitted against COVID-19. This time, Novartis is planning to study anti-inflammatory med Ilaris in a phase 3 trial to see if it can reverse severe immune overreactions in patients with COVID-19.

More: Novartis, already trialing hydroxychloroquine and Jakafi, plans COVID-19 testing for Ilaris
Source: fierce